Search Results

Syapse® and the FDA Oncology Center of Excellence renewed a four-year agreement to collaboratively develop and implement specific research projects to advance the use of real-world data and explore the potential strengths and limitations of using real-world evidence to inform regulatory objectives.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, has entered a collaboration with Merck, known as MSD, outside the United States and Canada, to leverage Syapse’s leading real-world evidence solutions designed to improve outcomes for cancer patients.

Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida.

Science 37 Holdings, Inc. and Syapse®, today announced a partnership to deploy proprietary real-world data intelligence and analytics that will help identify suitable patients for oncology clinical trials—ultimately speeding up the enrollment process.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced that Pfizer will continue working with Syapse to advance the use of real-world data from the Syapse Learning Health Network™, as an extension of the organizations’ ongoing collaboration.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced that they have entered into a strategic partnership with Genesis Research, combining the expertise and resources of both companies to better serve clients developing new oncology innovations.

Syapse® announced that long-time board member and health industry veteran Frank Williams has been named as Chairman of the company’s board of directors.

Syapse® presented five abstracts at Virtual ISPOR Europe 2021 , the leading global conference for health economics and outcomes research (HEOR), held last week.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new studies focused on how the use of machine learning on real-world data can be used to power precision medicine solutions.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced a collaboration with Main Line Health, home to four of the Philadelphia region’s most respected acute care hospitals.